.. don't get this post wrong I am talking longer rather than short term, and who knows the share price may pull back further in the short term..
but
current market cap is $350M. they are scheduled to sell between 10-15k dose of illumet in 2019. assuming (and that is always a big if) they get FDA approval at some point and even sell 20000 doses at $3000 per dose then that is $60M revenue. for a p/e of 50 (which is not unheard of for a company that is expected to have strong growth) the current market cap requires $7M earnings (profit).
and that is only for illumet, not the other programs..
I stand by this company being a multi $B market cap within a few years.
obviously there are a lot of ifs in the above.. dyor
just my 2 cents
why I like telix
Add TLX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.86 |
Change
0.055(0.37%) |
Mkt cap ! $4.933B | |||
| Open | High | Low | Value | Volume |
| $14.71 | $15.02 | $14.61 | $6.674M | 449.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 713 | $14.85 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.86 | 1065 | 14 |
View Market Depth
| Last trade - 11.54am 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$14.80 |
Change
0.055 ( 0.17 %) |
||||
| Open | High | Low | Volume | ||
| $14.73 | $15.02 | $14.62 | 83691 | ||
| Last updated 12.13pm 03/05/2024 ? | |||||
| TLX (ASX) Chart |